Cargando…

An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents

BACKGROUND: The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the standard first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). Due to the toxicity of this treatment, alternative therapies are often offered to patients. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Péron, Julien, Polivka, Valentine, Chabaud, Sylvie, Poupart, Marc, Ceruse, Philippe, Ramade, Antoine, Girodet, Didier, Zrounba, Philippe, Fayette, Jérôme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096421/ https://www.ncbi.nlm.nih.gov/pubmed/25011678 http://dx.doi.org/10.1186/1471-2407-14-504

Ejemplares similares

Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
por: Fayette, Jérôme, et al.
Publicado: (2016)

Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma
por: Fayette, Jérôme, et al.
Publicado: (2015)

Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma
por: Karabajakian, Andy, et al.
Publicado: (2020)

Addendum: Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma
por: Karabajakian, Andy, et al.
Publicado: (2022)

Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule
por: Pêtre, Adeline, et al.
Publicado: (2018)

Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neck
por: Guenne, Clémence, et al.
Publicado: (2014)

Addictions, Social Deprivation and Cessation Failure in Head and Neck Squamous Cell Carcinoma Survivors
por: Nokovitch, Lara, et al.
Publicado: (2023)

Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors
por: Foy, Jean-Philippe, et al.
Publicado: (2022)

Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers
por: Ortiz-Cuaran, Sandra, et al.
Publicado: (2021)

Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Question of Belief
por: Karabajakian, Andy, et al.
Publicado: (2018)

A New Animal Model of Laryngeal Transplantation
por: Philouze, Pierre, et al.
Publicado: (2022)

The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality
por: Ferrari, Daris, et al.
Publicado: (2020)

Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity
por: Deneuve, Sophie, et al.
Publicado: (2021)

Massive Multinodular Head and Neck Recurrence of Parotid Gland Pleomorphic Adenoma: A Case Report
por: Philouze, Pierre, et al.
Publicado: (2014)

Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy
por: Benkafadar, Nesrine, et al.
Publicado: (2016)

The role of EGFR-targeting strategies in the treatment of head and neck cancer
por: Dequanter, Didier, et al.
Publicado: (2012)

The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapy
por: Bentahila, Rita, et al.
Publicado: (2022)

NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell
por: Zhao, Zhi-Li, et al.
Publicado: (2016)

STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell
por: Bu, Lin-Lin, et al.
Publicado: (2015)

Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC’s)
por: Bétrian, Sarah, et al.
Publicado: (2017)

Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors
por: Tran, Bao-Tram Thi, et al.
Publicado: (2022)

CD44, γ-H2AX, and p-ATM Expressions in Short-Term Ex Vivo Culture of Tumour Slices Predict the Treatment Response in Patients with Oral Squamous Cell Carcinoma
por: Philouze, Pierre, et al.
Publicado: (2022)

Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study
por: Assaad, Souad, et al.
Publicado: (2021)

p38 MAPK pathway and its interaction with TRF2 in cisplatin induced chemotherapeutic response in head and neck cancer
por: Roy, Shomereeta, et al.
Publicado: (2018)

Abstract 86: Altered Iron-Mediator Expression Identifies Chemotherapeutic Effects of Deferoxamine on Head and Neck Squamous Cell Carcinoma
por: Donneys, Alexis, et al.
Publicado: (2019)

TRPM7 via calcineurin/NFAT pathway mediates metastasis and chemotherapeutic resistance in head and neck squamous cell carcinoma
por: Chen, Tsung-Ming, et al.
Publicado: (2022)

Chemoresistant fibroblasts dictate neoadjuvant chemotherapeutic response of head and neck cancer via TGFα-EGFR paracrine signaling
por: Su, Liangping, et al.
Publicado: (2023)

Mucosal Melanoma of the Head and Neck: A Retrospective Review and Current Opinion
por: Pincet, Laurence, et al.
Publicado: (2021)

Le peuple des fourmis
por: Ramade, François
Publicado: (1965)

Eléments d'écologie appliquée: action de l'homme sur la biosphère
por: Ramade, François
Publicado: (1974)

Trabectedin and its potential in the treatment of soft tissue sarcoma
por: Cassier, Philippe A, et al.
Publicado: (2008)

Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus–Driven Head and Neck Cancer: Current Evidence and Future Prospects
por: Aggarwal, Nikita, et al.
Publicado: (2021)

Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: phase II UNICANCER trial ORL03
por: Fayette, Jerome, et al.
Publicado: (2017)

CHEMOTHERAPEUTIC EQUILIBRIA
por: Stearn, Allen E., et al.
Publicado: (1930)

Chemotherapeutic Antiseptics
por: Browning, C. H.
Publicado: (1937)

Novel Resveratrol and 5-Fluorouracil Coencapsulated in PEGylated Nanoliposomes Improve Chemotherapeutic Efficacy of Combination against Head and Neck Squamous Cell Carcinoma
por: Mohan, Aarti, et al.
Publicado: (2014)

Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer
por: Ghasemi, Farhad, et al.
Publicado: (2017)

Inhibition of EIF2α Dephosphorylation Decreases Cell Viability and Synergizes with Standard-of-Care Chemotherapeutics in Head and Neck Squamous Cell Carcinoma
por: Cyran, Anna M., et al.
Publicado: (2023)

Road Map for Nanocrystal Based Infrared Photodetectors
por: Livache, Clément, et al.
Publicado: (2018)

Preventive and Therapeutic Effect of Metformin in Head and Neck Cancer: A Concise Review
por: Bouland, Cyril, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ifvt2gqsl5svlcpr9gui1e1ocv